Geode Capital Management’s Firefly Neuroscience AIFF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$341K Buy
156,308
+42,992
+38% +$53.5K ﹤0.01% 3721
2025
Q4
$99.2K Hold
113,316
﹤0.01% 4099
2025
Q3
$330K Sell
113,316
-7,288
-6% -$20.6K ﹤0.01% 3757
2025
Q2
$341K Buy
120,604
+58,067
+93% +$184K ﹤0.01% 3678
2025
Q1
$246K Buy
62,537
+2,295
+4% +$10.6K ﹤0.01% 3778
2024
Q4
$160K Buy
60,242
+2,884
+5% +$8.94K ﹤0.01% 3965
2024
Q3
$174K Buy
57,358
+53,472
+1,376% +$280K ﹤0.01% 3946
2024
Q2
$24K Hold
3,886
﹤0.01% 4424
2024
Q1
$40.3K Hold
3,886
﹤0.01% 4364
2023
Q4
$19.5K Buy
3,886
+1
+0% +$6 ﹤0.01% 4520
2023
Q3
$29.1K Buy
3,885
+896
+30% +$9.17K ﹤0.01% 4545
2023
Q2
$28.7K Hold
2,989
﹤0.01% 4606
2023
Q1
$26K Hold
2,989
﹤0.01% 4654
2022
Q4
$43K Sell
2,989
-7
-0.2% -$163 ﹤0.01% 4635
2022
Q3
$85K Hold
2,996
﹤0.01% 4626
2022
Q2
$120K Buy
2,996
+1,206
+67% +$116K ﹤0.01% 4515
2022
Q1
$283K Buy
+1,790
New +$242K ﹤0.01% 4206

Other funds holding AIFF

Geode Capital Management's AIFF Position: Q1 2026 in Review

Geode Capital Management increased its Firefly Neuroscience (AIFF) stake by 38% in Q1 2026, buying an estimated $53.5K and bringing the position to 156,308 shares worth $341K. The position accounts for ﹤0.01% of the portfolio, ranked #3721.

Geode Capital Management first reported a position in AIFF in Q1 2022 and has held it in 17 quarters since. The position peaked at $341K in Q2 2025. 23 funds tracked by Wall St. Rank hold AIFF as of Q1 2026.

  • Geode Capital Management held 156,308 shares of Firefly Neuroscience worth $341K as of Q1 2026.
  • Geode Capital Management bought 42,992 Firefly Neuroscience shares in Q1 2026, an estimated $53.5K.
  • Firefly Neuroscience made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #3721 holding.
  • Geode Capital Management first reported a position in Firefly Neuroscience in Q1 2022 and has held it in 17 quarters since.
  • Geode Capital Management's Firefly Neuroscience position peaked at $341K in Q2 2025.
  • 23 funds tracked by Wall St. Rank held Firefly Neuroscience as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.